Emergent BioSolutions, Inc. (EBS) Tops Q4 EPS by 11c; Reaffirms FY11 Outlook
Tweet Send to a Friend
Emergent BioSolutions, Inc. (NYSE: EBS) reported Q4 EPS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
